This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland

Phil Morton
Chief Technology Officer at Albumedix
Speaker

Profile

Dr. Phil Morton has more than 25 years of experience in the biopharmaceutical industry, where he has worked across process development, product development, and product application research. As CTO of Albumedix, Dr. Morton leads a team of specialists to refine recombinant albumin technologies and fully leverage albumin’s multifaceted capabilities.

Agenda Sessions

  • Why focusing on a quality end product from the beginning makes sense | Managing your journey to commercialization with quality raw materials.

    12:30